Travere Therapeutics, Inc. (Nasdaq: TVTX) today reported its second quarter 2026 financial results and provided a corporate update. “With an exceptional second quarter, Travere has entered a new ...
Progress has been made in achieving equality and freedoms for women, but advancing these gains further requires constant ...